Skip to content
value.today

Selkirk Pharma, Inc.

Total raised
$82 M
5 rounds on record
Latest round
$24 M
Aug 2023
First round on record
Feb 2018
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Selkirk Pharma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2023$24 MNo. 5$10 to $50 million

Selkirk Pharma, Inc.: Raise no. 5, Aug 2023

Investors in this round

114 investors had bought by the notice of Sep 13, 2023: 114 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $25 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Joe Herzog · Executive Officer, Director
  • Patrick Haffey · Executive Officer, Director
  • Marshall Crew · Director
  • Rod Raabe · Director
  • Tom Tobin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Haffey, President and CEO. Source: SEC Form D, newest notice filed Sep 13, 2023. Read the notice at the SEC.

equitySEC
Dec 2021$35 MNo. 4$10 to $50 million

Selkirk Pharma, Inc.: Raise no. 4, Dec 2021

Investors in this round

137 investors had bought by the notice of Dec 30, 2021: 137 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Joe Herzog · Executive Officer, Director
  • Patrick Haffey · Executive Officer, Director
  • Rod Raabe · Director
  • Tom Tobin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Haffey, President. Source: SEC Form D, newest notice filed Dec 30, 2021. Read the notice at the SEC.

equitySEC
Aug 2020$12 MNo. 3$10 to $50 million

Selkirk Pharma, Inc.: Raise no. 3, Aug 2020

Investors in this round

79 investors had bought by the notice of Sep 15, 2020: 79 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $15 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Patrick Haffey · Executive Officer, Director
  • Joe Herzog · Director
  • Rod Raabe · Director
  • Tom Tobin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Haffey, President. Source: SEC Form D, newest notice filed Sep 15, 2020. Read the notice at the SEC.

equitySEC
Feb 2020$9 MNo. 2$2 to $10 million

Selkirk Pharma, Inc.: Raise no. 2, Feb 2020

Investors in this round

65 investors had bought by the notice of Feb 25, 2020: 65 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $18 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Patrick Haffey · Executive Officer, Director
  • Joe Herzog · Director
  • Rod Raabe · Director
  • Tom Tobin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “INCLUDES CONVERSION OF PROMISSORY NOTES”

Signed by Partick Haffey, President. Source: SEC Form D, newest notice filed Feb 25, 2020. Read the notice at the SEC.

equitySEC
Feb 2018$2 MNo. 1Under $2 million

Selkirk Pharma, Inc.: Raise no. 1, Feb 2018

Investors in this round

19 investors had bought by the notice of Mar 2, 2018: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Patrick Haffey · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Partick Haffey, President. Source: SEC Form D, newest notice filed Mar 2, 2018. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Selkirk Pharma, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).

    SEC Form D · Sep 2023

  • The industry group it chose in its notices: Manufacturing.

    SEC Form D · Sep 2023

That is all the official record says: Selkirk Pharma, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Selkirk Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 137 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Selkirk Pharma, Inc.
NameRoleNamed in
Joe HerzogExecutive officerSep 2023
Patrick HaffeyExecutive officerSep 2023
Joe HerzogDirectorSep 2023
Marshall CrewDirectorSep 2023
Patrick HaffeyDirectorSep 2023
Rod RaabeDirectorSep 2023
Tom TobinDirectorSep 2023